Overview
Status
Suspended
Registry date
2023-03-13
Share capital
5,000.00 PLN
Registered address
Krakowskie Przedmieście 16/18/29a, 00-325 Warszawa, Poland
Financials
Filing timeliness
No financial statement for 2024 – the filing deadline has passed.
- 2024not filed
- 202310/07/2024
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Industry
Authorized Representatives
Piotr Andrzej Kędzierski – President of the Management Board
Manner of representation
Each member of the management board is authorized to make declarations on behalf of the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Piotr Kędzierskiage 44 | 10 | $270.12 | 20% |
| 40 | $1,080.50 | 80% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Was a VAT taxpayer from 2023-05-12 to 2024-12-13.
Reason for removal: Art. 96 ust. 9a pkt 2 (VAT returns not filed for 3 consecutive months or a quarter)
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Państwowy Instytut Medyczny Ministerstwa Spraw Wewnętrznych i AdministracjiResearch institute | $355,967,543.57 | cskmswia.pl | ||
| FamicordtxS.A. | $1,365,068.41 | famicordtx.com | ||
| Medicofarma BiotechS.A. | $314,882.33 | medicofarmabiotech.pl | ||
| Explorna Therapeuticssp. z o.o. | $304,662.00 | explorna.com | ||
| Frontline BiosciencesS.A. | $219,186.29 | frontlinebiosciences.com | ||
| Stenocoatsp. z o.o. | $36,665.21 | stenocoat.com | ||
| Bioselsp. z o.o. | $19,100.32 | selol.pl | ||
| Wavex Energysp. z o.o. | $142.33 | wavexenergy.com | ||
| Nawah Scientific Polandsp. z o.o. | – | nawah-scientific.com | ||
| LASTsp. z o.o. | – | last-skincare.com |
Change history
| Date | Event | |
|---|---|---|
| 2025-12-03 | Address change (Ul. Hoża 42/33, 00-516, Warszawa → Krakowskie Przedmieście 16/18/29a, 00-325, Warszawa) | |
| 2025-02-20 | Address change (Ul. Williama Heerleina Lindleya 16, 02-013, Warszawa → Ul. Hoża 42/33, 00-516, Warszawa) | |
| 2024-12-12 | Business suspended | |
| 2023-03-13 | Entered in the register |
FAQ
The main business activity of Suerto focuses on research and experimental development on biotechnology.
The company was registered in the Polish National Court Register (KRS) on March 13, 2023.
The headquarters is located at: Krakowskie Przedmieście 16/18, 00-325 Warszawa.
The management board consists of: Piotr Andrzej Kędzierski (President of the Management Board).
The share capital of the company is PLN 5,000 (approx. $1,351).
The latest available financial statement covers the period from March 9, 2023 to December 31, 2023.
Last updated: 2026-04-21